Officers with the U.S. Marshals Service have seized all skin sanitizers and skin protectants, including ingredients and components, at Clarcon Biological Chemistry Laboratory’s facility in Roy, Utah. The Food and Drug Administration warned the public last month not to use any Clarcon products because they contain harmful bacteria and are promoted as antimicrobial agents that claim to treat open wounds, damaged skin, and protect against various infectious diseases. Thus far, no cases have been reported to the FDA. Clarcon voluntarily recalled the affected products, marketed under several different brand names, in June 2009, following an FDA inspection that revealed high levels of potentially disease-causing bacteria in the products.
The inspection also uncovered serious deviations from the FDA’s regulations, including poor practices that permitted the contamination. The seizure by the FDA of these products, along with their ingredients, occurred after Clarcon failed to promptly destroy them. The FDA said it is protecting the public by preventing these products from entering the marketplace. Deborah M. Autor, director of the FDA’s Center for Drug Evaluation and Research Office of Compliance, had this to say:
The FDA is committed to taking enforcement action against firms that do not manufacture drugs in accordance with our current good manufacturing practice requirements.
Clarcon has produced over 800,000 bottles of these products and distributed them in several regions of the country since 2007. The FDA says consumers should not use any Clarcon products and should dispose of them in their household trash. Analyses of several samples of the topical antimicrobial skin sanitizer and skin protectant products revealed high levels of various bacteria. The FDA warns that some of these bacteria can cause opportunistic infections of the skin and underlying tissues. Such infections may need medical or surgical attention and may result in permanent damage, according to the FDA.
Source: ABC News
Contact us today for a free legal consultation with an experienced attorney.
Fields marked *may be required for submission.
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.